Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma
Dipika R. Mohan, Antônio Marcondes Lerário, Tobias Else, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 11, pp. 3276-3288
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Overview of the 2022 WHO Classification of Adrenal Cortical Tumors
Özgür Mete, Lori A. Erickson, C. Christofer Juhlin, et al.
Endocrine Pathology (2022) Vol. 33, Iss. 1, pp. 155-196
Open Access | Times Cited: 183
Adrenocortical carcinoma — towards genomics guided clinical care
Joakim Crona, Felix Beuschlein
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 9, pp. 548-560
Closed Access | Times Cited: 110
CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle
Yugang Huang, Dan Li, Li Wang, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 42
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study
Massimo Terzolo, Martin Faßnacht, Paola Perotti, et al.
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 10, pp. 720-730
Open Access | Times Cited: 37
New perspectives for mitotane treatment of adrenocortical carcinoma
Soraya Puglisi, Anna Calabrese, Valentina Basile, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2020) Vol. 34, Iss. 3, pp. 101415-101415
Open Access | Times Cited: 70
What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics
C. Christofer Juhlin, Jérôme Bertherat, Thomas J. Giordano, et al.
Endocrine Pathology (2021) Vol. 32, Iss. 1, pp. 102-133
Closed Access | Times Cited: 50
Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner
Kate Warde, Lorenzo J. Smith, Lihua Liu, et al.
Nature Aging (2023) Vol. 3, Iss. 7, pp. 846-865
Open Access | Times Cited: 21
A Diagnostic Approach to Adrenocortical Tumors
Anjelica Hodgson, Sara Pakbaz, Özgür Mete
Surgical pathology clinics (2019) Vol. 12, Iss. 4, pp. 967-995
Closed Access | Times Cited: 36
Artificial Intelligence in Epigenetic Studies: Shedding Light on Rare Diseases
Sandra Brasil, Cátia J. Neves, Tatiana Rijoff, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 29
ENDOCRINE TUMOURS: Our experience with the management of patients with non-metastatic adrenocortical carcinoma
Massimo Terzolo, Martin Faßnacht
European Journal of Endocrinology (2022) Vol. 187, Iss. 3, pp. R27-R40
Closed Access | Times Cited: 21
Advances in translational research of the rare cancer type adrenocortical carcinoma
Chandrayee Ghosh, Jiangnan Hu, Electron Kebebew
Nature reviews. Cancer (2023) Vol. 23, Iss. 12, pp. 805-824
Closed Access | Times Cited: 12
Adrenal Cortical Carcinoma

American Registry of PathologyArlington, Virginia eBooks (2024), pp. 131-183
Closed Access | Times Cited: 4
Past, Present and Future of Epigenetics in Adrenocortical Carcinoma
Madeleine H. T. Ettaieb, Thomas Kerkhofs, Manon van Engeland, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1218-1218
Open Access | Times Cited: 28
Update on Biology and Genomics of Adrenocortical Carcinomas: Rationale for Emerging Therapies
Antônio Marcondes Lerário, Dipika R. Mohan, Gary D. Hammer
Endocrine Reviews (2022) Vol. 43, Iss. 6, pp. 1051-1073
Open Access | Times Cited: 19
Adrenocortical carcinoma: a practical guide for clinicians
Martin Faßnacht, Soraya Puglisi, Otilia Kimpel, et al.
The Lancet Diabetes & Endocrinology (2025)
Open Access
G0S2 Promotes PD-L1 Expression in Monocytes and Influences the Efficacy of PD-1 Inhibitors in Hepatocellular Carcinoma
Xueming Du, Wenwen Zhang, Sujuan Sun, et al.
Genes (2025) Vol. 16, Iss. 4, pp. 448-448
Open Access
Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
Tito Fojo, Lyn M. Huff, Thomas Litman, et al.
BMC Medical Genomics (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 23
Multi-dimensional data integration algorithm based on random walk with restart
Yuqi Wen, Xinyu Song, Bowei Yan, et al.
BMC Bioinformatics (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 19
Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
Ruaa Al-Ward, Celeste Zsembery, Mouhammed Amir Habra
Endocrine Oncology (2022) Vol. 2, Iss. 1, pp. R90-R101
Open Access | Times Cited: 13
β-Catenin–Driven Differentiation Is a Tissue-Specific Epigenetic Vulnerability in Adrenal Cancer
Dipika R. Mohan, Kleiton Silva Borges, Isabella Finco, et al.
Cancer Research (2023) Vol. 83, Iss. 13, pp. 2123-2141
Open Access | Times Cited: 8
The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model
Roberta Armignacco, Giulia Cantini, G Poli, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1931-1931
Open Access | Times Cited: 20
Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study
Juliane Lippert, Ulrich Dischinger, Silke Appenzeller, et al.
European Journal of Endocrinology (2023) Vol. 189, Iss. 2, pp. 262-270
Open Access | Times Cited: 7
Adrenocortical carcinoma: current treatment options
Giuseppina De Filpo, Massimo Mannelli, Letizia Canu
Current Opinion in Oncology (2020) Vol. 33, Iss. 1, pp. 16-22
Closed Access | Times Cited: 18
Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes
Qian Wang, Na Sun, Raphael Meixner, et al.
JCI Insight (2023) Vol. 8, Iss. 16
Open Access | Times Cited: 6
Pathological and Genetic Stratification for Management of Adrenocortical Carcinoma
Michael R. Clay, Emília M. Pinto, Lauren Fishbein, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 107, Iss. 4, pp. 1159-1169
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top